Combined genetic attenuation of myelin and semaphorin-mediated growth inhibition is insufficient to promote serotonergic axon regeneration.
about
Nogo limits neural plasticity and recovery from injuryProtease regulation: the Yin and Yang of neural development and diseaseChondroitin sulphate N-acetylgalactosaminyl-transferase-1 inhibits recovery from neural injuryUnderstanding the NG2 Glial Scar after Spinal Cord InjuryA perspective on the role of class III semaphorin signaling in central nervous system traumaAxon regeneration mechanisms: insights from C. elegansProBDNF collapses neurite outgrowth of primary neurons by activating RhoA.Astrocyte scar formation aids central nervous system axon regeneration.In vivo imaging of dorsal root regeneration: rapid immobilization and presynaptic differentiation at the CNS/PNS border.Wallerian degeneration: gaining perspective on inflammatory events after peripheral nerve injury.Transforming growth factor α transforms astrocytes to a growth-supportive phenotype after spinal cord injuryExtrinsic and intrinsic determinants of nerve regenerationFibronectin inhibits chronic pain development after spinal cord injuryPhenotypic Screening of Small-Molecule Inhibitors: Implications for Therapeutic Discovery and Drug Target Development in Traumatic Brain Injury.Sensory Axon Regeneration: A Review from an in vivo Imaging Perspective.Axon Guidance Molecules and Neural Circuit Remodeling After Spinal Cord Injury.Perivascular fibroblasts form the fibrotic scar after contusive spinal cord injuryLack of serotonin reuptake during brain development alters rostral raphe-prefrontal network formation.Role of myelin-associated inhibitors in axonal repair after spinal cord injury.Plexin structures are coming: opportunities for multilevel investigations of semaphorin guidance receptors, their cell signaling mechanisms, and functions.Multiple sclerosis: does Nogo play a role?Spinal cord regeneration: where fish, frogs and salamanders lead the way, can we follow?PirB is a novel potential therapeutic target for enhancing axonal regeneration and synaptic plasticity following CNS injury in mammals.Myelin-associated inhibitors in axonal growth after CNS injury.Serotonergic transmission after spinal cord injury.Scar-modulating treatments for central nervous system injury.Spinal cord injury and the neuron-intrinsic regeneration-associated gene program.Central nervous system regenerative failure: role of oligodendrocytes, astrocytes, and microglia.In vitro models of axon regeneration.CNS repair and axon regeneration: Using genetic variation to determine mechanisms.Cell biology of spinal cord injury and repair.Regrowth of Serotonin Axons in the Adult Mouse Brain Following Injury.In Vivo Imaging of CNS Injury and Disease.Serotonin axons in the neocortex of the adult female mouse regrow after traumatic brain injury.Integrins promote axonal regeneration after injury of the nervous system.
P2860
Q26861883-9204BEE9-AFC6-47F9-A38A-D249EAF3021AQ27000161-A8C9BF91-2CBA-4C7F-86F5-57FDE1616C31Q27682773-BDBA5C02-368F-471E-AEAC-0CCFEB95FB6CQ28078778-D11AA89F-6693-459C-B880-643B164DF8FBQ28251368-1021E4B1-A09C-45F2-BF4A-7E20CDC084D2Q34015740-44ED0201-0141-42AE-9F8C-86FB9FFA6DF3Q34256867-15C5DFD5-5E76-4B04-A693-2445771B7E0FQ34520260-1C81C980-BE1A-4541-B28C-E0C59F711B5BQ34749899-800B7D14-5867-43EB-8248-A37A2495F45AQ35232779-4DF65866-8714-40F7-BDB0-D8008186D8E1Q35543006-27C51842-5DF4-4A6F-821F-E1484BA33C36Q35654115-C9653402-E8BA-4609-B7FE-40F06E7B580EQ35754899-146105EF-6B04-4D96-966A-BF74B589BAFDQ36125734-CEA8BD72-8EE4-4E9B-9F53-041589B3C273Q36267846-844DFEF4-21A8-4CE1-98F1-32D29D0D3E01Q36775227-2541460D-3B02-4312-9B7B-6636D7B0C15EQ37128159-CB76BD83-2107-4AB9-AB22-91764DEF2985Q37214031-E9FD7D91-74E2-4B39-BCC1-07EA38934143Q37877302-E86C2712-17DD-4DED-97BE-E3694CD89FFCQ38022543-FE2E311A-28B3-40B4-8083-8E7A16EF7E74Q38082999-CEE4E6D6-FDDE-4BC8-A701-518B636E075CQ38098567-63BA7D2F-6B8F-4AFD-9B11-3EEA053706F8Q38176947-592EC9D2-0F61-40A0-B03C-67539027C6A8Q38194402-AEF4C4D8-2ECB-46B5-9EE1-BBEB9C2BC052Q38215361-1B452D51-61EB-40BE-8845-1EA4BF5DB675Q38222632-55B37137-2582-4001-93EF-509FE373C1A7Q38255644-1133DB25-AF6B-4F58-BFCA-26785F420F9DQ38283108-5C71CAA4-E521-446F-9EB6-02FB908E72E3Q38716618-01395842-FA2B-4024-8962-3385FB459EADQ38830850-6AC7CAD6-5E11-48CE-9F8A-83E38ADB8F82Q39454081-8AF33282-0B8E-445C-B8DB-9D65854ABD23Q41580785-58D87A38-370F-4788-8354-2540424ADC26Q46495043-B3EA176B-4FF5-4A26-847B-F08AF83368E8Q47769778-9F00E428-559D-450A-AB49-B888D4D2FBCFQ49989826-400DD14B-085A-4B45-9567-7CD369F72189
P2860
Combined genetic attenuation of myelin and semaphorin-mediated growth inhibition is insufficient to promote serotonergic axon regeneration.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Combined genetic attenuation o ...... erotonergic axon regeneration.
@ast
Combined genetic attenuation o ...... erotonergic axon regeneration.
@en
Combined genetic attenuation o ...... erotonergic axon regeneration.
@nl
type
label
Combined genetic attenuation o ...... erotonergic axon regeneration.
@ast
Combined genetic attenuation o ...... erotonergic axon regeneration.
@en
Combined genetic attenuation o ...... erotonergic axon regeneration.
@nl
prefLabel
Combined genetic attenuation o ...... erotonergic axon regeneration.
@ast
Combined genetic attenuation o ...... erotonergic axon regeneration.
@en
Combined genetic attenuation o ...... erotonergic axon regeneration.
@nl
P2093
P2860
P1476
Combined genetic attenuation o ...... erotonergic axon regeneration.
@en
P2093
Binhai Zheng
Kristine E Tolentino
Renee Chow
Sharon Y Chow
P2860
P304
10899-10904
P356
10.1523/JNEUROSCI.2269-10.2010
P407
P577
2010-08-01T00:00:00Z